TECAN LIMITED
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Fabricated Structural Metal, Miscellaneous Structural Metal Work, Fabricated Metal Products, Not Elsewhere Classified, Manufacturing Industries, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about TECAN LIMITED
Live alerts from global media, monitored by Business Radar
2024-10-15 (frontiersin.org)
Capsaicin attenuates the effect of inflammatory cytokines in a HaCaT cell model for basal keratinocytes
IntroductionThe resolution of the skin’s inflammatory response is only possible if its barrier function is restored. TRPV1 channel activation plays an import...
Read more
2024-08-23 (rsc.org)
Biodegradation of hydroxylated boron nitride nanoplatelets, their toxic effect and drug delivery application
Boron nitride is extensively used in various biomedical applications and often interacting with the blood circulatory system. However, the effect of its biotransformation in blood plasma, drug delivery applications, and antitumor effects remains unclear.
Read more
2024-03-18 (biomedcentral.com)
Cytoprotective role of human dental pulp stem cell-conditioned medium in chemotherapy-induced alopecia - Stem Cell Research & Therapy
Background Chemotherapy-induced alopecia (CIA) is a distressing adverse effect of chemotherapy, with an estimated incidence of 65% and limited treatment options. Cyclophosphamide (CYP) is a common alopecia-inducing chemotherapy agent. Human dental pulp stem cells( DPSCs) secrete several paracrine
Read more
2022-01-11 (nature.com)
Targeting prooxidant MnSOD effect inhibits triple-negative breast cancer (TNBC) progression and M2 macrophage functions under the oncogenic stress
Triple-negative breast cancer (TNBC) has been shown with high mitochondrial oxidative phosphorylation and production of reactive oxygen species (ROS). MnSOD (SOD2) is a mitochondrial antioxidant defense that has been implicated in inhibition of human malignancies. However, the impact of MnSOD on
Read more
2020-08-09 (marketscreener.com)
4-week preview of Switzerland
Below are the most important economic and financial dates from August 12th, 2020 - September 8th, 2020: August 12th. Addex: Result Q2 Zurich Airport: Traffic figures July 2020 Glarner KB: Result...
Read more
2020-08-07 (marketscreener.com)
EVOLVA HOLDING SA : Stock market news and information | EVE | CH0021218067 | MarketScreener
EVOLVA HOLDING SA : News, news and information Share EVOLVA HOLDING SA | EVE | CH0021218067 | Swiss Exchange
Read more
2020-07-11 (marketscreener.com)
4-week preview of Switzerland
Below are the most important economic and financial dates from 08/10/2020 - 09/06/2020: 08/10. Seco: Labor market data July 2020 11.08. BCGE: Result H1, MK H1 Datwyler: Result H1 ...
Read more
2020-07-08 (marketscreener.com)
4-week preview of Switzerland
Below are the most important economic and financial dates from August 7th, 2020 - September 3rd, 2020: August 7th. Conzzeta: Result H1 Orell Füssli: Result H1 Coltene: Result H1 SNB:...
Read more
2017-01-03 (nature.com)
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity
The cannabinoid CB2 receptor (CB2R) represents a promising therapeutic target for various forms of tissue injury and inflammatory diseases. Although numerous compounds have been developed and widely used to target CB2R, their selectivity, molecular mode of action and pharmacokinetic properties have been poorly characterized. Here we report the most extensive characterization of the molecular pharmacology of the most widely used CB2R ligands to date. In a collaborative effort between multiple academic and industry laboratories, we identify marked differences in the ability of certain agonists to activate distinct signalling pathways and to cause off-target effects. We reach a consensus that HU910, HU308 and JWH133 are the recommended selective CB2R agonists to study the role of CB2R in biological and disease processes. We believe that our unique approach would be highly suitable for the characterization of other therapeutic targets in drug discovery research.
Read more
2016-07-06 (nature.com)
Inhibitory effect of 2methylnaphtho123dequinolin8one on melanosome transport and skin pigmentation Scientific Reports
Scientific Reports - Inhibitory effect of 2-methyl-naphtho[1,2,3-de]quinolin-8-one on melanosome transport and skin pigmentation
Read more
2016-07-06 (nature.com)
Inhibitory effect of 2methylnaphtho123dequinolin8one on melanosome transport and skin pigmentation Scientific Reports
Scientific Reports - Inhibitory effect of 2-methyl-naphtho[1,2,3-de]quinolin-8-one on melanosome transport and skin pigmentation
Read more
1930-08-09 (ahajournals.org)
Effect of an siRNA Therapeutic Targeting PCSK9 on Atherogenic Lipoproteins
Background: The ORION-1 trial (Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol [LDL-C]) demonstrated that inclisiran, an siRNA therapeutic that targets prot
Read more